Physician Assistant Program year 2024 Reported 2023–2024 Source: CMS Open Payments, 2026 publication

Kristina Johnson

Physician Assistant Ames, IA Physician Assistant

NPI 1760553150 CMS profile 10698609

3600 Lincoln Way, Ames, IA 50014

Open in the dashboard

General payments

$1,278

23 records reported · program years 2023–2024

Research payments

$0

Paid to them · None reported · program years 2023–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Kristina Johnson of Ames, IA is reported in the CMS Open Payments database as having received $1,278 across 23 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $1,227 21
2023 General $51 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kristina Johnson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kristina Johnson were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kristina Johnson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $51 $167 $52–$557 $160
2024 $1,227 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2023–2024
  1. Medtronic, Inc. $1,043 15 payments
  2. AbbVie, Inc. $57 1 payment
  3. Boston Scientific Corporation $48 1 payment
  4. Pacira Pharmaceuticals Incorporated $35 1 payment
  5. Piramal Critical Care $35 2 payments
  6. BIOTRONIK NRO, Inc. $27 1 payment
  7. SPR Therapeutics, Inc $18 1 payment
  8. Vertos Medical, Inc. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2024
  1. Travel and Lodging $673 5 payments
  2. Food and Beverage $458 15 payments
  3. Education $147 3 payments
Products named General payments · program years 2023–2024
  1. SYNCHROMEDII $900 11 payments
  2. INTELLIS ADAPTIVESTIM $143 4 payments
  3. BOTOX $57 1 payment
  4. Iovera $35 1 payment
  5. Zilretta $35 1 payment
  6. GABLOFEN Pharmacology $35 2 payments
  7. GABLOFEN Pharmacology $35 2 payments
  8. GABLOFEN Pharmacology $35 2 payments
  9. GABLOFEN Pharmacology $35 2 payments
  10. Prospera $27 1 payment
  11. Other $34 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

325

Median for Physician Assistant: 241

Drug cost

$3,432

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 109 $1,571
Pregabalin Generic 65 $1,128
Methylprednisolone Generic 58 $376
Baclofen Generic 93 $357

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$85,373

Of which drugs: $1,344

Medicare patients

519

Average age 76

Services billed

2,165

325 women, 194 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 33%
Diabetes 29%
Chronic kidney disease 28%
Ischemic heart disease 24%
Atrial fibrillation 20%
Osteoporosis 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 51 296 $221
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 52 224 $20

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $57
$57 — —
GABLOFEN
  • Piramal Critical Care $35
$35 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

23 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record